Diagnostic Yield of Agitated Exudative Non-infected Pleural Effusion
A Feasibility Study of the Diagnostic Yield of Pre-aspiration Pleural Fluid Agitation in Non-infected Pleural Effusion
1 other identifier
interventional
55
1 country
1
Brief Summary
The goal of this study is to compare the diagnostic yield in terms of cellular content and biochemical characteristics of pre-aspiration agitated pleural fluid versus that of conventionally aspirated fluid in pleural infection patients. The hypothesis is that the agitated fluid would be more representative and thus may aid the diagnosis of non-infected exudative pleural effusions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedFirst Submitted
Initial submission to the registry
April 6, 2023
CompletedFirst Posted
Study publicly available on registry
April 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedApril 21, 2023
April 1, 2023
11 months
April 6, 2023
April 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Diagnostic yield of the cytological analysis
Percentage of samples with a positive cytological result among both aspiration techniques
14 days
Diagnostic yield of the microbiolocal analysis (mycobacterial / fungal)
Percentage of samples with a evidence of mycobacterial / fungal elements among both aspiration techniques
14 days
Incidence of adverse events with pre-aspiration fluid agitation
Percentage of patients with incidence of adverse events during or right after pre-aspiration fluid agitation including pneumothorax or significant pain or cough or oxygen desaturation
14 days
Secondary Outcomes (5)
Protein level difference between both aspiration method
results within 1 day of sampling
Lactate dehydrogenase (LDH) level difference between both aspiration method
results within 1 day of sampling
Glusose level difference between both aspiration method
results within 1 day of sampling
Neutrophilic count difference between both aspiration method
results within 1 day of sampling
Lymphocytic count difference between both aspiration method
results within 1 day of sampling
Study Arms (1)
Standard thoracentesis followed by pre-aspiration fluid agitation
EXPERIMENTALParticipants will undergo the standard thoracentesis followed by the experimental pre-aspiration fluid agitation technique
Interventions
Using a 16-18 gauge cannula, a standard thoracentesis will be performed then a sample of pleural fluid will be aspirated and rapidly flushed into the pleural space and redrawn again for a few cycles before a sample is finally drawn into the collection syringe
Eligibility Criteria
You may qualify if:
- Age \> 18 years old
- At least a moderate amount of pleural fluid collection (2 or more intercostal spaces on thoracic ultrasound)
You may not qualify if:
- Minimal - mild pleural fluid deemed unsuitable for aspiration and agitation
- Hemodynamic instability
- Pleural infection based on clinical presentation, imaging or laboratory investigations and pleural fluid examination showing glucose \< 40 mg/dL or pH \<7.2 with lower respiratory infection, positive gram stain or bacterial culture or pus on aspiration
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chest Diseases Department, Alexandria University Faculty of Medicine
Alexandria, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Laboratory personnel responsible for the cytological and biochemical analysis will be blinded to the identity of the paired samples
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
April 6, 2023
First Posted
April 19, 2023
Study Start
April 1, 2023
Primary Completion
March 1, 2024
Study Completion
April 1, 2024
Last Updated
April 21, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share